Autolus Therapeutics plc (AUTL) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 26.22M | 24.25M | 21.19M | 20.92M | 8.98M | 29K | 0 | 0 | 10.09M | 0 | 406K | 0 |
| Revenue Growth % | 191.89% | 83534.17% | - | - | -10.99% | - | -100% | - | 681.04% | -100% | -82.86% | - |
| Cost of Goods Sold | 24.57M | 25.29M | 28.64M | 24.45M | 17.95M | 138.3M | 1.22M | 0 | 1.81M | 1.77M | 1.52M | 0 |
| COGS % of Revenue | 93.71% | 104.29% | 135.15% | 116.83% | 199.86% | 476910.34% | - | - | 17.9% | - | 375.62% | - |
| Gross Profit | 1.65M | -1.04M | -7.45M | -3.52M | -8.97M | -138.28M | -1.22M | 0 | 8.29M | -1.77M | -1.12M | 0 |
| Gross Margin % | 6.29% | -4.29% | -35.15% | -16.83% | -99.86% | -476810.34% | - | - | 82.1% | - | -275.62% | - |
| Gross Profit Growth % | 118.4% | 99.25% | -511.58% | - | -208.26% | -7690.14% | -8.85% | - | 1464.91% | -184.08% | 96.83% | - |
| Operating Expenses | 61.16M | 71.32M | 64.17M | 57.7M | 56.27M | 103.15M | 67.65M | 58.93M | 47.04M | 39.11M | 42.93M | 44.35M |
| OpEx % of Revenue | 233.29% | 294.06% | 302.78% | 275.75% | 626.45% | 355693.1% | - | - | 466.18% | - | 10573.65% | - |
| Selling, General & Admin | 39.95M | 35.74M | 36.28M | 30.27M | 29.53M | 42.48M | 27.33M | 21.9M | 16.37M | 13.95M | 10.61M | 11.12M |
| SG&A % of Revenue | 152.39% | 147.36% | 171.18% | 144.65% | 328.81% | 146479.31% | - | - | 162.23% | - | 2613.55% | - |
| Research & Development | 21.21M | 35.58M | 27.89M | 27.43M | 26.73M | 50.53M | 40.32M | 36.61M | 30.67M | 25.16M | 32.32M | 33.23M |
| R&D % of Revenue | 80.9% | 146.7% | 131.6% | 131.1% | 297.64% | 174241.38% | - | - | 303.94% | - | 7960.1% | - |
| Other Operating Expenses | 0 | 1 | 0 | 0 | 0 | 1000K | 0 | 414K | 0 | 0 | 0 | 0 |
| Operating Income | -59.51M | -72.36M | -71.62M | -61.22M | -65.24M | -241.43M | -68.87M | -58.93M | -38.76M | -40.89M | -44.05M | -44.35M |
| Operating Margin % | -226.99% | -298.35% | -337.93% | -292.58% | -726.31% | -832503.45% | - | - | -384.07% | - | -10849.26% | - |
| Operating Income Growth % | 8.77% | 70.03% | -3.99% | -3.88% | -68.32% | -490.49% | -56.35% | -32.86% | -9.54% | -34.95% | 45.7% | 4.58% |
| EBITDA | -56.82M | -69.73M | -68.26M | -56.91M | -62.96M | -239.35M | -66.93M | -54.74M | -36.95M | -39.11M | -42.67M | -42.84M |
| EBITDA Margin % | -216.72% | -287.52% | -322.06% | -271.98% | -700.96% | -825341.38% | - | - | -366.18% | - | -10509.61% | - |
| EBITDA Growth % | 9.75% | 70.87% | -1.98% | -3.95% | -70.39% | -511.97% | -56.87% | -27.78% | -10.36% | -36.83% | 46.22% | 3.86% |
| D&A (Non-Cash Add-back) | 2.69M | 2.63M | 3.36M | 4.31M | 2.28M | 2.08M | 1.94M | 4.18M | 1.81M | 1.77M | 1.38M | 1.51M |
| EBIT | -59.51M | -72.36M | -68.07M | -61.22M | -57.79M | -75.86M | -67.65M | -48.05M | -33.43M | -34.68M | -42.52M | -40.49M |
| Net Interest Income | -8.64M | -19.58M | -6.14M | 12.06M | -4.01M | 38.28M | -2.37M | -518K | -12.34M | -27.12M | -1.37M | -1.62M |
| Interest Income | 2.47M | 3.22M | 4.38M | 12.06M | 6.14M | 7.45M | 8.32M | 9.66M | 6.93M | 3.01M | 3.65M | 3.4M |
| Interest Expense | 11.11M | 22.8M | 10.52M | 0 | 10.14M | -30.84M | 10.69M | 10.17M | 19.27M | 30.13M | 5.01M | 5.02M |
| Other Income/Expense | -11.22M | -19.02M | -6.96M | 13.7M | -2.7M | 215.28M | -13.2M | 708K | -13.94M | -23.92M | -1.82M | -1.16M |
| Pretax Income | -70.73M | -91.38M | -78.59M | -47.52M | -67.94M | -26.14M | -82.07M | -58.22M | -52.7M | -64.81M | -45.87M | -45.51M |
| Pretax Margin % | -269.8% | -376.78% | -370.79% | -227.12% | -756.36% | -90151.72% | - | - | -522.23% | - | -11298.03% | - |
| Income Tax | 861.55K | -1.18M | 532K | 397K | 2.23M | 1.46M | 22K | 51K | -8K | 12.36M | -21K | 40K |
| Effective Tax Rate % | -1.22% | 1.29% | -0.68% | -0.84% | -3.28% | -5.59% | -0.03% | -0.09% | 0.02% | -19.07% | 0.05% | -0.09% |
| Net Income | -71.6M | -90.2M | -79.12M | -47.92M | -70.16M | -27.61M | -82.09M | -58.27M | -52.69M | -77.17M | -45.85M | -45.55M |
| Net Margin % | -273.09% | -371.91% | -373.3% | -229.02% | -781.13% | -95193.1% | - | - | -522.15% | - | -11292.86% | - |
| Net Income Growth % | -2.05% | -226.75% | 3.63% | 17.77% | -33.16% | 64.23% | -79.05% | -27.92% | -32.35% | -186.34% | -7.21% | -8.3% |
| Net Income (Continuing) | -71.6M | -90.2M | -79.12M | -47.92M | -70.16M | -27.61M | -82.09M | -58.27M | -52.69M | -77.17M | -45.85M | -45.55M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 | -0.10 | -0.31 | -0.22 | -0.24 | -0.44 | -0.26 | -0.26 |
| EPS Growth % | -3.85% | -240% | 3.23% | 18.18% | -8.33% | 77.27% | -19.23% | 15.38% | -4.35% | -91.3% | 44.68% | 43.48% |
| EPS (Basic) | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 | -0.10 | -0.31 | -0.22 | -0.24 | -0.44 | -0.26 | -0.26 |
| Diluted Shares Outstanding | 266.14M | 266.14M | 266.14M | 266.14M | 266.13M | 266.13M | 266.08M | 266.03M | 222.17M | 174.03M | 173.98M | 173.86M |
| Basic Shares Outstanding | 266.14M | 266.14M | 266.14M | 266.14M | 266.13M | 266.13M | 266.08M | 266.03M | 222.17M | 174.03M | 173.98M | 173.86M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |